Former Mozambican president Joaquim Chissano is in the country to open the 8th annual Stakeholders Meeting of Medicines for Malaria Venture (M .M. V).
The MMV is a non-profit organisation dedicated to reducing the burden of malaria in disease endemic countries by discovering, developing and facilitating the delivery of effective and affordable antimalarial drugs through public-private partnerships.
A press statement issued by the MMV, stated that after eight years of operation, the organisation is managing the largest ever portfolio of malaria drug research with nearly 40 projects at different stages of drugs research and development.
The meeting, which will be held under the theme, Mission Possible, aims at highlighting the bold vision of malaria eradication and MMV’s critical role in this mission.
The organisation will hold its second Annual Access symposium tomorrow, where the keynote speaker will be Dora Akunyili, Director General of Nigeria’s National Agency for Food and Drugs Administration and Control.
The MMV, which focuses on developing the best medicines for people at risk of malaria, is expected to launch its first new drug at the end of the year.


US and Iran reach deal to end war, reopen Hormuz
French-UK mission 'ready' to aid Hormuz reopening, says Macron
Putin’s paranoia: AI espionage pushes Kremlin to reinforce security measures
With Europe closed, migrants stalled in Mauritania limbo
G7 summit opens in France with Ukraine war, new US-Iran agreement on agenda
Macron leads effort to bridge divides with Trump at France's G7 summit
US and Iran agree to memorandum of understanding and immediate end to military o...
KMA Deploys Vacuum Sweepers to Tackle Dust, Waste and Flooding in Kumasi
BoG Extends IMTO Registration Deadline to July 31 — Non‑Compliant Operators Face...
Big Payout, Big Changes: MMMF Declares 30p Dividend, Endorses New Board